Cargando…

Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

BACKGROUND: Long-term use of benzodiazepine receptor agonists (BZRAs) remains common despite European guidelines advising that these drugs be used in the lowest possible dose and for the shortest possible duration. Half of all BZRAs are prescribed in family practice. This creates a window of opportu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coteur, Kristien, Van Nuland, Marc, Schoenmakers, Birgitte, Anthierens, Sibyl, Van den Broeck, Kris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132004/ https://www.ncbi.nlm.nih.gov/pubmed/37027198 http://dx.doi.org/10.2196/43738

Ejemplares similares

Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary care
por: Coteur, Kristien, et al.
Publicado: (2022)

“At the time I only wanted to relieve stress”: Exploring motivation for behaviour change in long-term hypnotic users
por: Coteur, Kristien, et al.
Publicado: (2023)

Effectiveness of a blended care programme for the discontinuation of benzodiazepine use for sleeping problems in primary care: study protocol of a cluster randomised trial, the Big Bird trial
por: Coteur, Kristien, et al.
Publicado: (2020)

Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study
por: Coteur, Kristien, et al.
Publicado: (2022)

Co-design to increase implementation of insomnia guidelines in primary care
por: Coteur, Kristien, et al.
Publicado: (2022)

Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics
por: Aoki, Yumi, et al.
Publicado: (2021)

‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
por: Ellen, Van Leeuwen, et al.
Publicado: (2021)

General practitioners’ perspectives on discontinuation of long-term antidepressants in nursing homes
por: Van Leeuwen, Ellen, et al.
Publicado: (2022)

Academic detailers’ and general practitioners’ views and experiences of their academic detailing visits to improve the quality of analgesic use: process evaluation alongside a pragmatic cluster randomized controlled trial
por: Anthierens, Sibyl, et al.
Publicado: (2017)

General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis
por: Sirdifield, Coral, et al.
Publicado: (2013)

Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders
por: Chapoutot, Mélinée, et al.
Publicado: (2021)

Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
por: Takeshima, Masahiro, et al.
Publicado: (2022)

Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference?
por: Kollen, Boudewijn J, et al.
Publicado: (2012)

Trends in the registration of anxiety in Belgian primary care from 2000 to 2021: a registry-based study
por: Beerten, Simon Gabriël, et al.
Publicado: (2023)

Benzodiazepine Receptor Agonists Prescribing for Insomnia Among Adults in Primary Health Care Facilities in Beijing, China
por: Fu, Mengyuan, et al.
Publicado: (2023)

Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care (ARON project): protocol for a cluster-randomized pragmatic trial
por: Verbakel, Jan Yvan Jos, et al.
Publicado: (2022)

Benzodiazepines prescribing in insomnia : Between practice and guidelines
por: Lagha, M., et al.
Publicado: (2021)

Teaching young GPs to cope with psychosocial consultations without prescribing: a durable impact of an e-module on determinants of benzodiazepines prescribing
por: Creupelandt, Hanne, et al.
Publicado: (2017)

A tailored e-learning gives long-term changes in determinants of GPs’ benzodiazepines prescribing: a pretest-posttest study with self-report assessments
por: Creupelandt, Hanne, et al.
Publicado: (2019)

Trends in the epidemiology of depression and comorbidities from 2000 to 2019 in Belgium
por: Walrave, Roosje, et al.
Publicado: (2022)

Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation
por: Fluyau, Dimy, et al.
Publicado: (2018)

Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey
por: Reid Finlayson, Alistair J., et al.
Publicado: (2022)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Associations of Benzodiazepine With Adverse Prognosis in Heart Failure Patients With Insomnia
por: Sato, Yu, et al.
Publicado: (2020)

Role of the prescriber in supporting patients to discontinue benzodiazepines: a qualitative study
por: Oldenhof, Erin, et al.
Publicado: (2021)

Long-term use of benzodiazepines in chronic insomnia: a European perspective
por: Soyka, Michael, et al.
Publicado: (2023)

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
por: Baandrup, Lone, et al.
Publicado: (2011)

Insomnia, Benzodiazepine Use, and Falls among Residents in Long-term Care Facilities
por: Jiang, Yu, et al.
Publicado: (2019)

Treatment of insomnia in myasthenia gravis—A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia
por: Yan, Jingwen, et al.
Publicado: (2023)

Discontinuation of hypnotics during cognitive behavioural therapy for insomnia
por: Zavesicka, Lucie, et al.
Publicado: (2008)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review
por: Capiau, Andreas, et al.
Publicado: (2022)

Discontinuation or reduction in benzodiazepine use by treatment with the traditional herbal medicine Hangekobokuto, case reports
por: Yoshinaga, Ryo, et al.
Publicado: (2020)

Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
por: Aoki, Yumi, et al.
Publicado: (2023)

Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines
por: Amari, Diana T., et al.
Publicado: (2022)

‘I just thought that it was such an impossible thing’: A qualitative study of barriers and facilitators to discontinuing long‐term use of benzodiazepine receptor agonists using the Theoretical Domains Framework
por: Lynch, Tom, et al.
Publicado: (2021)

Electrophysiological and Neuropsychological Indices of Cognitive Dysfunction in Patients with Chronic Insomnia and Severe Benzodiazepine Use Disorder
por: Castelnovo, Anna, et al.
Publicado: (2023)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Differences in Benzodiazepine Receptor Agonist Use in Rural and Urban Older Adults
por: Mattos, Meghan K., et al.
Publicado: (2016)

The Impact of Dementia's Affiliate Stigma on the Mental Health of Relatives: A Cross Section Survey
por: Van den Bossche, Pauline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4762v5h14dmuprosrctk4ihghd